RobertT.SperlingMD
Cardiology • Larkspur, CAAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Physician
Dr. Sperling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Bon Air Rd
#100
Larkspur, CA 94939Phone+1 415-927-0666Fax+1 415-927-6168
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Interventional Cardiology, 2001 - 2002- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1998 - 2001
Brigham and Women's HospitalResidency, Internal Medicine, 1995 - 1998
Duke University School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2002 - 2025- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 12 citationsPlatelet glycoprotein IIb/IIIa inhibition with eptifibatide: prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis.Robert T. Sperling, Duane S. Pinto, Kalon K.L. Ho, Joseph P. Carrozza
Catheterization and Cardiovascular Interventions. 2003-08-01 - 17 citationsHigh incidence of focal left ventricular wall motion abnormalities and normal coronary arteries in patients with myocardial infarctions presenting to a community hospi...Brian Strunk, Richard E. Shaw, Sally Bull, James Adams, Margaret Baer
The Journal of Invasive Cardiology. 2006-08-01 - 8 citationsCombination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocyto...Duane S. Pinto, Robert T. Sperling, Thomas M. Tu, David J. Cohen, Joseph P. Carrozza
Catheterization and Cardiovascular Interventions. 2003-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
